Dna Group (T.R.) Valuation
Is DNA undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of DNA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: DNA (₪0.89) is trading above our estimate of fair value (₪0.05)
Significantly Below Fair Value: DNA is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for DNA?
Key metric: As DNA is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is DNA's PE Ratio? | |
|---|---|
| PE Ratio | 7.3x |
| Earnings | ₪15.05m |
| Market Cap | ₪109.99m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 139.4x |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does DNA's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 12.4x | ||
INTR Inter Gamma Investment | 14.5x | n/a | ₪134.1m |
ORAD Orad | 8.5x | n/a | ₪64.8m |
UNIT Unitronics (1989) (RG) | 7.9x | n/a | ₪403.9m |
NXSN NextVision Stabilized Systems | 18.6x | n/a | ₪4.1b |
DNA Dna Group (T.R.) | 7.3x | n/a | ₪110.0m |
Price-To-Earnings vs Peers: DNA is good value based on its Price-To-Earnings Ratio (7.3x) compared to the peer average (12.4x).
Price to Earnings Ratio vs Industry
How does DNA's PE Ratio compare vs other companies in the Asian Electronic Industry?
| 37 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 37 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: DNA is good value based on its Price-To-Earnings Ratio (7.3x) compared to the Asian Electronic industry average (24.6x).
Price to Earnings Ratio vs Fair Ratio
What is DNA's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 7.3x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate DNA's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
C-Lab
₪96.4m
Manufactures and sells ARM-based computer-on-module and system-on-module products worldwide.
CLAB
₪11.37
7D
2.6%
1Y
-14.4%
Unitronics (1989) (RG)
₪403.9m
Designs, develops, produces, markets, and sells, programmable logic controllers (PLC) and other automation products in Israel and internationally.
UNIT
₪28.97
7D
-5.8%
1Y
-7.1%
AudioCodes
US$259.7m
Provides advanced communications software, products, and productivity solutions for the digital workplace worldwide.
AUDC
US$32.40
7D
1.9%
1Y
-20.0%